Cannabis Law Blog

  On May 21, 2024, the United States Department of Justice through the DEA issued a notice of proposed rulemaking (NPRM) proposing to transfer "marijuana" from Schedule I of the Controlled Substances Act to Schedule III. Schedules of Controlled Substances: Rescheduling of Marijuana, 89 Fed. Reg. 44597, 44597 (2024).    In an order dated August 29, 2024 (General Notice of Hearing or GNoH) , the DEA Administrator determined that in-person hearing proceedings are appropriate and fixed a December 2, 2024 commencement date at the DEA Hearing Facility.   On October 29, 2024, the DEA Administrator released a list of twenty-five “participants” (Designated Participants or DPs). However, the Hon. John J. Mulrooney, II, Chief Administrative Law Judge, issued a Preliminary Order on October 31 , stating that the DP list failed to specify whether the “participants” support or oppose the NPRM or how the “participants” satisfy the “interested person” definition set forth in th...

Last September, the 2nd European Cannabis Law Conference took place in Dortmund, organized by the INCBA Europe conference team with Kai-Friedrich Niermann, Daniel Haymann, Marie Sanchez and Robert Jappie. The conference took place alongside the Cannabis Business Expo and Intertabac, the largest global tobacco trade fair. With 7 tracks and 28 speakers, current topics in global cannabis law were discussed over two days, from the reclassification of cannabis in the USA and its global consequences, semi-synthetic cannabinoids in the USA and Europe, GMP requirements, to the emerging market for medical cannabis in Ukraine and much more. The conference was accompanied by an extensive social program for networking, which the international cannabis legal scene thoroughly enjoyed.  Here are some session highlights:  Ukraine recently legalized medical cannabis and significantly de-regulated industrial hemp. The government and Ministry of health of Ukraine have approved subordinate legis...